Discoverability where trust, accuracy and compliance decide everything.
Pharma operates in the highest-stakes information space there is. We build the authority, accuracy and technical foundations that earn visibility responsibly — for patients and professionals alike.
- Visibility gated to high-authority institutional sources
- Slow review cycles throttling content velocity
- Two audiences, one estate: patients and professionals
Why pharma needs a specialist.
This is YMYL at the limit
Health information is held to the strictest trust and accuracy standards. Authority isn’t a nice-to-have — it is the price of entry.
Compliance is non-negotiable
Regulatory and medical-legal review shape every word. Discoverability has to work inside those constraints, not around them.
Two distinct audiences
Patients and healthcare professionals search differently and need different evidence. One system has to serve both, credibly.
The relevant disciplines.
YMYL & authority signals
Build the experience, expertise and trust signals health visibility depends on.
Medical content accuracy
Evidence-led content with clear authorship, review and citation trails.
Regulatory-compliant content
Workflows that move quickly while staying inside medical-legal review.
International & multilingual
Accurate, compliant localisation across markets and regulators.
Healthcare search behaviour
Map how patients and professionals actually search and decide.
Technical foundations
Structured data, crawl health and performance for complex estates.
Technical, content and authority — together.
- +Structured data for medical & condition content
- +Clean architecture across brand & disease sites
- +Performance on regulated, asset-heavy pages
- +Accessibility as a first-class requirement
- +Evidence-led, reviewable content systems
- +Clear authorship, dating & citation trails
- +Patient vs. professional content pathways
- +Localisation with medical-legal sign-off
- +E-E-A-T rebuilt around real expertise
- +Citations from recognised health sources
- +Author and organisation entity authority
- +Reputation across professional surfaces
Compliant in every market.
Pharma discoverability rarely stops at one border. We localise accuracy and compliance together, so each market meets its own regulator without diluting authority.
The receipts.
+176% condition-content visibility
We rebuilt authorship and trust signals, shipped reviewable content systems and earned citations from recognised health sources — without a single compliance escalation.
Pharmaceuticals discoverability, engineered.
Tell us the markets and surfaces that matter. We’ll show you where you surface today, where you don’t, and the system that closes the gap.